Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Filed Apr 2, 2018 · 10-K · 92 days after period end · 0001615774-18-002312
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|
| Revenue | — | $0.00 | — |
| Net Income | -$1.17M | -$1.24M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Apr 2, 2018 · 92 d after period end
